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Introduction
Monoamniotic twinning accounts for 1% of monozygotic
twins [1]. The incidence of congenital anomalies is 2.5
times higher in monozygotic twins than in dizygotic
twins or singletons [2]. Acardiac twinning (Figures 1–4)
occurs in 1% of monozygotic twins, or 1 in 35,000 births
[3]. Acardiac twinning is caused by the development of
arterioarterial vascular anastomoses between the
umbilical arteries of monozygotic twins early in
embryogenesis. A pump twin (donor) perfuses an
acardiac twin (recipient) through the arterioarterial
anastomoses. This twin disorder is also known as the
twin reversed arterial perfusion (TRAP) sequence [4].
The forms of the acardiac twin have been classified into
four types: acardius acormus (5%), in which only the head
is developed; acardius anceps (8%), in which the fetus has
a rudimentary head and an imperfect face, but the body
and extremities are usually present; acardius amorphus
(25%), in which the fetus has no recognizable human
form except for a uniform, skin-covered mass containing
the rudiments of muscle, bone, cartilage, and other
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tissues; and acardius acephalus (62%), in which the fetus
is characterized by the lack of a head, upper limbs, and
thoracic organs, but the lower limbs are well developed
[5–7]. Prenatal diagnosis of an oval mass around the
placenta should include a differential diagnosis of
acardius amorphus, and prompt a search for the connecting
umbilical cord and a distinction between the placental
teratoma and acardius amorphus by ultrasound. A
placental teratoma has neither umbilical cord formation
nor skeleton development in the craniocaudal direction,
whereas an acardius amorphus has an umbilical cord
consisting of one artery and one vein and a rudimentary
axial organization of skeletal development [8,9].
In the pregnancy with acardiac twinning, the pump
twin may be associated with congenital malformations
(Figure 4). In their studies, Sato et al [10] and Moore et
al [11] found an 8.3% and 9% incidence of major
congenital anomalies in pump twins, respectively. In a
review of the literature over a period of 20 years, Buntinx
et al found an 11% incidence of anomalies in pump
twins [12]. The reported anomalies included tetralogy
of Fallot, single ventricle, aortic arch anomalies, patent
ductus arteriosus, anencephaly, rachischisis, exom-
phalos, micrognathia, low-set ears, VATER associa-
tion (vertebral defects, anal atresia, tracheoesopha-
geal fistula with esophageal atresia, renal defects, and
radial dysplasia), brain anomalies, renal anomalies,
chromosomal abnormalities, prune belly sequence,
Figure 3. (A) Acardiac twin C with an omphalocele, a
rudimentary head, an imperfect face, and poorly developed
upper limbs; (B) the well-developed lower limbs of acardiac
twin C; (C) roentgenogram of acardiac twin C.
Figure 4. (A) Anomalous pump twin D with limb-reduction
defects of the left upper limb, and acardiac twin D with
rudimentary skeleton (inset); (B) prenatal ultrasound of pump
twin D shows hypoplasia of the upper limb, arthrogryposis of
the wrist (arrow), and left hand digital deficiency (d = digit);
(C) prenatal ultrasound of pump twin D shows left congenital
diaphragmatic hernia (H = heart; L = lungs; S = stomach).
Figure 1. (A) Normal pump twin A (left) and acardiac twin A
(right); (B) acardiac twin A; (C) the rudimentary head and
imperfect face of acardiac twin A; (D) roentgenogram of the
rudimentary skull of acardiac twin A.
Figure 2. (A) Acardiac twin B; (B) the poorly developed upper
limb of acardiac twin B; (C) the poorly developed fingers of
acardiac twin B.
  A B
  C D
  A B
C
  A C
  B
  A B
C
Prenatal Management of Acardiac Twinning
107Taiwanese J Obstet Gynecol • June 2005 • Vol 44 • No 2
urinary tract obstruction, and anal atresia [12]. Healey
reported that chromosomal abnormalities occurred in
33% of acardiac twins and 8.8% of pump twins [13].
Therefore, it is recommended that prenatal genetic
testing be offered whenever pregnancy is complicated
by acardiac twinning. Molecular zygosity analysis has
proven that twins discordant for the TRAP sequence
anomaly are monozygous [14].
The treatment options for acardiac twinning include
observation, medical management, amniodrainage, and
invasive treatment such as hysterotomy with selective
delivery of the acardiac twin, intrafetal ablation of the
acardiac twin by alcohol, radiofrequency, laser or
thermocoagulation, ultrasound-guided funicular
occlusion by ligation, cord compression, thermocoag-
ulation or intrafunicular embolization with foreign
bodies, and fetoscope-guided funicular occlusion by
ligation, laser or thermocoagulation. If parents opt for
either noninvasive management of the pump twin or
invasive treatment of the acardiac twin, clinicians should
first carefully search for any possible associated anomaly
in the pump twin by both genetic testing and sonographic
examination.
Medical Management
Magnesium sulfate, `-mimetics and indomethacin
have been used to prevent and treat premature uterine
contractions, and corticosteroid administration has
been used to accelerate fetal lung maturity. Of concern
are the side effects of pulmonary edema in the mother
from `-mimetics, and necrotizing enterocolitis in the
fetus, constriction of the fetal ductus arteriosus and
long-term vasculoconstriction of the fetal renal
arteries from indomethacin [15]. Ash et al used
indomethacin to improve polyhydramnios and to
reduce the increased cardiac output in the pump twin
[16]. Simpson et al used digoxin and digitalization of
the mother to treat the cardiac failure of the pump
twin in late gestation [17]. However, maternal
digitalization for fetal cardiac failure and maternal
usage of  indomethacin for  improvement of
polyhydramnios are not efficacious; they may not be
able to solve the problems of the earlier-diagnosed
and more severely threatened pump twins and may
delay definitive treatment [15,18].
Amniodrainage
Platt et al used amniodrainage to decompress the
polyhydramnios caused by the TRAP sequence, even
though there was no correction of the pathophysiologic
mechanism [19]. Repeated amniodrainage is able to
relieve painful distension of the abdominal wall and
uterus, as well as prevent preterm labor initiated by the
distended uterus [15]. However, amniodrainage in
polyhydramnios should be used with caution because
repeated amniodrainage may lead to placental
abruption, chorioamnionitis, and great variations in
fetal blood flow and cerebral blood flow that may result
in neurologic damage [15]. Sepulveda and Sebire
suggested that amniodrainage to treat polyhydramnios
associated with acardiac twinning is not useful in
correcting the underlying hemodynamic pathophysio-
logy which causes progressive cardiovascular demand
on the pump twin [18].
Invasive Treatment
Hysterotomy and selective delivery of the
acardiac twin
Hysterotomy and selective delivery of the acardiac twin
has been used as an interventional method for the
treatment of acardiac twinning [20–22]. However, the
invasiveness of hysterotomy, which is associated with
maternal morbidity such as infection, hemorrhage,
uterine rupture, and complications from aggressive
tocolytic therapy, limits its application. Robie et al first
described hysterotomy with selective delivery of the
acardiac twin at 22 weeks’ gestation and subsequent
delivery of a 2,130-g surviving pump twin at 33 weeks’
gestation [20]. At least eight cases have been reported
[20–22], but there were four cases of premature rupture
of membranes (PROM), three cases of preterm delivery
of the pump twin before 30 weeks of gestation, one of
intrauterine death of the pump twin, two cases of
maternal pulmonary edema, and three placental
abruptions.
Intrafetal alcohol ablation
Absolute alcohol is a well-known vessel sclerosant that
has been widely used to interrupt blood supply to
lesions by the process of chemosclerosis. Holzgreve et al
injected multiple pieces of standard suture material
soaked in 96% ethanol into the umbilical cord of the
acardiac twin with an amniocentesis needle [23]. This
procedure caused an immediate interruption of the
blood flow in the cord at 21 weeks of gestation. Sepulveda
et al later modified this technique by directly injecting
absolute alcohol into the intra-abdominal segment of
the single umbilical artery of the acardiac twin under
color Doppler guidance [24]. To date, at least 12 cases
have been reported (Table 1) [24–31]. Among them, 10
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Table 1. Clinical outcome of acardiac twinning treated with intrafetal alcohol ablation
IUFD
Preterm Preterm
Survival
GW at GW at of
delivery or delivery or
of Technical
Authors [Reference]
treatment delivery pump
PROM ) 2 PROM
pump success
twin
weeks of ) 32
twin
procedure GW
Sepulveda et al [24] 23 25 – + + Yes Yes
Denbow et al [25]
   Case D 22 22 + + + No No
Sepulveda et al [26]
   Case 1 27 35 – – – Yes Yes
   Case 2 26 37 – – – Yes Yes
Tongsong et al [27] 25 34 – – – Yes Yes
Heredia & Quiroz [28] 22 22 + + + No Yes
Sepulveda et al [29]
   Case 3 26 37 – – – Yes Yes
   Case 5 20 23 – – + Yes Yes
   Case 7 21 21 + + + No Yes
   Case 8 32 32 + + + No Yes
Ozeren et al [30] 16 27 – – + No No
Porreco [31] 17 39 – – – Yes Yes
GW = gestational weeks; IUFD = intrauterine fetal death; PROM = premature rupture of membranes.
cases were technically successful, seven pump twins
survived, and there were seven cases of preterm delivery
or PROM at 32 gestational weeks or less.
Intrafetal alcohol ablation has the advantages of
being a simple and inexpensive technique. However, the
passage of alcohol into the circulation of the pump twin
remains a major concern. Sepulveda et al observed
acute thrombosis of the umbilical vessels of the pump
twin in one case because of accidental transfer of the
alcohol, and transient bradycardia in the pump twins in
two cases [29]. So, although intrafetal alcohol ablation
is a simple and effective method of occlusion of vascular
supply to the acardiac twin, Sepulveda et al suggested
that the use of this technique should be restricted to
those pregnancies with poor prognostic factors and in
fetal medicine units where more sophisticated methods
for treatment are not available [29].
Intrafetal radiofrequency ablation
Radiofrequency ablation (RFA) is commonly used to
treat liver lesions, and it was first introduced to obliterate
the blood flow in the acardiac twin by Tsao et al [32].
Under sonographic guidance, an RFA needle device is
inserted percutaneously into the mid-abdomen of the
acardiac twin at the level of the umbilical artery and
vein. After intervention, satisfactory coagulation is
confirmed when cessation of blood flow to the acardiac
twin is confirmed on Doppler ultrasound.
To date, at least 14 cases have been reported (Table
2) [32,33]. Among them, all were technically successful,
13 pump twins survived, and there were four cases of
delivery or PROM at 32 gestational weeks or less.
Selective reduction of the acardiac twin with RFA has
proven to be minimally invasive and effective for
obliterating blood perfusion of the acardiac twin.
Intrafetal RFA can be performed in the second trimester
without any technical difficulty, and fetal hydrops may
resolve until delivery.
Intrafetal laser ablation
Percutaneous ultrasound-guided laser coagulation of
the intra-abdominal vessels (such as the intra-abdominal
segment of the single umbilical artery, intrapelvic
vessels, and abdominal aorta) has been reported to be
an effective technique to ablate the acardiac twin
[34–37]. Jolly et al were the first to use an interstitial
laser in two pregnancies complicated by TRAP sequence
at 14 and 15 weeks of gestation, respectively [34]. A
600-+m laser fiber was introduced from a 17-gauge
needle into the abdomen of the acardiac twin close to
the vitelline artery and intrahepatic vein. A neodymium:
yttrium-aluminum-garnet (Nd:YAG) laser was fired in
short bursts until blood flow in the vitelline artery and
the intrahepatic vein stopped. The two pregnancies
resulted in the birth of healthy pump twins at term.
Soothill et al later reported a modification of the
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Table 2. Clinical outcome of acardiac twinning treated with intrafetal radiofrequency ablation
IUFD
Preterm Preterm
Survival
GW at GW at of
delivery or delivery or
of Technical
Authors [Reference]
treatment delivery pump
PROM ) 2 PROM
pump success
twin
weeks of ) 32
twin
procedure GW
Tsao et al [32]
   Case 1 22 24 + + + No Yes
   Case 2 19 38 – – – Yes Yes
   Case 3 19 26 – – + Yes Yes
   Case 4 21 37 – – – Yes Yes
   Case 5 17 38 – – – Yes Yes
   Case 6 23 38 – – – Yes Yes
   Case 7 19 39 – – – Yes Yes
   Case 8 18 38 – – – Yes Yes
   Case 9 20 38 – – – Yes Yes
   Case 10 21 32 – – + Yes Yes
   Case 11 19 40 – – – Yes Yes
   Case 12 23 38 – – – Yes Yes
   Case 13 20 37 – – – Yes Yes
Hirose et al [33] 27 32 – – + Yes Yes
GW = gestational weeks; IUFD = intrauterine fetal death; PROM = premature rupture of membranes.
technique using ultrasound-guided laser ablation of
the pelvic vessels within the abdomen of the acardiac
twin [35]. Sepulveda et al described successful ultra-
sound-guided laser ablation of a large acardiac twin at
26 weeks’ gestation by laser coagulation of the intra-
abdominal vessels [36]. Weisz et al reported successful
intra-abdominal laser coagulation of the acardiac twin
in two cases by in utero YAG-laser occlusion of the intra-
abdominal vessels of the acardiac twin and obliteration
of the blood flow [37]. To date, at least seven cases
have been reported (Table 3) [34–37]. All were technically
successful, all pump twins survived, and there was only
one case of delivery or PROM at 32 gestational weeks
or less.
The main advantages of intrafetal laser ablation are
that the technique is simple to perform under ultrasound
guidance by positioning the laser fiber within the body
of the acardiac twin rather than the cord, and that it can
be performed during early gestation under local
anesthesia as with other outpatient invasive needle
Table 3. Clinical outcome of acardiac twinning treated with intrafetal laser ablation
IUFD
Preterm Preterm
Survival
GW at GW at of
delivery or delivery or
of Technical
Authors [Reference]
treatment delivery pump
PROM ) 2 PROM
pump success
twin
weeks of ) 32
twin
procedure GW
Jolly et al [34]
   Case 1 15 Term – – – Yes Yes
   Case 2 14 Term – – – Yes Yes
Soothill et al [35]
   Case 1 18 38 – – – Yes Yes
   Case 2 16 38 – – – Yes Yes
Sepulveda et al [36] 26 36 – – – Yes Yes
Weisz et al [37]
   Case 5 22 32 – – + Yes Yes
   Case 6 15 37 – – – Yes Yes
GW = gestational weeks; IUFD = intrauterine fetal death; PROM = premature rupture of membranes.
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procedures. In a review of the literature on acardiac
twins treated with minimally invasive techniques, Tan
and Sepulveda concluded that intrafetal ablation is
simpler, safer and more effective than the cord occlusion
technique [38].
Intrafetal monopolar thermocoagulation
Rodeck et al were the first to perform ultrasound-
guided thermocoagulation with a wire electrode passing
through an 18-gauge needle, which was then guided
into the lumen of the acardiac twin’s aorta if the vessel
was of sufficient size, or the tip of the needle was placed
near the intra-abdominal vessel if the vessel lumen was
too small [39]. The advantages of ultrasound-guided
intrafetal monopolar thermocoagulation are that it is
simple, quick, inexpensive, and similar to fetal-blood
sampling. It is especially useful when the cord of the
acardiac twin is short, poorly visualized or edematous.
This technique only requires identification of the main
intra-abdominal vessel in the body of the acardiac twin
and can be performed early in pregnancy. To date, at
least 15 cases have been reported (Table 4) [39–43]. All
were technically successful, 10 pump twins survived,
and seven cases had delivery or PROM at 32 gestational
weeks or less.
Ultrasound-guided funicular occlusion by ligation, cord
compression, thermocoagulation or intrafunicular
embolization with foreign bodies
Ultrasound-guided funicular occlusion techniques
include intrafunicular embolization with metallic coil,
fibrin clot or alcohol-soaked suture material, ligation
with Foley Cordostat, cord compression, and thermo-
coagulation. Hamada et al were the first to success-
fully use a steel coil placed in the umbilical cord close
to the abdominal wall of the acardiac twin under ultra-
sound guidance at 23 weeks’ gestation in 1989 [44].
Porreco et al described another successful case in 1991
[45].
Intrafunicular injection and mechanical embolization
of the umbilical artery under ultrasound guidance has
been performed using foreign bodies such as fibrin clot
[46], alcohol-soaked suture material [23], and metallic
coils [47,48] (Table 5). Foley et al reported successful
treatment of an acardiac twin pregnancy by selective
ligation of the pump twin’s umbilical cord with an
intrauterine cord grasping device, the Foley Cordostat
[49]. Subsequently, other ultrasound-guided funicular
occlusion techniques were developed, including cord
compression [50], monopolar thermocoagulation
[39,40], and bipolar diathermy [50–52] (Table 5). The
Table 4. Clinical outcome of acardiac twinning treated with intrafetal monopolar thermocoagulation
IUFD
Preterm Preterm
Survival
GW at GW at of
delivery or delivery or
of Technical
Authors [Reference]
treatment delivery pump
PROM ) 2 PROM
pump success
twin
weeks of ) 32
twin
procedure GW
Rodeck et al [39]
   Case 2 18 39 – – – Yes Yes
   Case 3 19 39 – – – Yes Yes
   Case 4 16 37 – – – Yes Yes
Holmes et al [40]
   Case 3 16 39 – – – Yes Yes
   Case 5 21 22 + + + No Yes
   Case 6 22 24 + + + No Yes
   Case 8 24 25 + + + No Yes
   Case 9 20 36 – – – Yes Yes
   Case 10 20 39 – – – Yes Yes
   Case 11 22 42 – – – Yes Yes
   Case 12 19 38 – – – Yes Yes
Chao et al [41] 23 32 – – + Yes Yes
Chang et al [42]
   Case 2 24 24 + + + No Yes
Sepulveda et al [43]
   Case 1 29 31 – + + Yes Yes
   Case 2 16 ? + ? + No Yes
GW = gestational weeks; IUFD = intrauterine fetal death; PROM = premature rupture of membranes.
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insertion of coil or fibrin clot has been associated with
the death of the pump twins [46,47]. Fetofetal hemor-
rhage through one of the non-thrombosed vessels in
the umbilical cord and the embolic phenomena distal to
the thrombus have been suggested as possible pathogen-
eses of the death of the pump twins in these cases [53].
To date, at least 12 cases of ultrasound-guided
funicular thermocoagulation have been described [39,
40,50–52] (Table 5). Among them, 10 cases were
successful, 10 pump twins survived, and there were four
cases of delivery or PROM at 32 gestational weeks or
less. In ultrasound-guided funicular occlusion, technical
difficulties may be encountered when there is juxta-
position of the cords of the acardiac twin and the pump
twin, or when the umbilical cord of the acardiac twin is
short and thin or edematous.
Fetoscope-guided funicular occlusion by ligation, laser
coagulation or thermocoagulation
McCurdy et al were the first to successfully ligate the
acardiac twin’s umbilical cord using an endoscopic
technique [54]. The acardiac twin’s umbilical cord was
identified with an endoscope, grasping forceps were
used to grasp the umbilical cord, and the cord was then
tightened with a knot-pusher. To date, at least 17 cases
of fetoscope-guided funicular ligation have been re-
ported [53–59] (Table 6). Among them, 14 cases were
successful, 10 pump twins survived, and there were 14
Table 5. Clinical outcome of acardiac twinning treated with ultrasound-guided funicular occlusion by ligation,
cord compression, thermocoagulation or intrafunicular embolization with foreign bodies
IUFD
Preterm Preterm
Survival
GW at GW at of
delivery or delivery or
of Technical
Authors [Reference] Method
treatment delivery pump
PROM ) 2 PROM
pump success
twin
weeks of ) 32
twin
procedure GW
Holzgreve et al [23] Alcohol-soaked 21 37 – – – Yes Yes
  suture material
Rodeck et al [39]
   Case 1 Monopolar 24 32 – – + Yes Yes
Holmes et al [40]
   Case 2 Monopolar 24 32 – – – Yes Yes
   Case 4 Monopolar 19 39 – – – Yes Yes
Hamada et al [44] Coil 23 38 – – – Yes Yes
Porreco et al [45] Coil 24 39 – – – Yes Yes
Grab et al [46]
   Case 1 Fibrin clot 24 24 + + + No No
Roberts et al [47] Coil 23 23 + + + No Yes
Tanawattanacharoen et al [48] Coil 24 24 + + + No Yes
Foley et al [49] Ligation with 22 35 – – – Yes Yes
  Foley Cordostat
Gallot et al [50]
   Case 5 Cord compression 21 38 – – – Yes Yes
   Case 6 Bipolar 23 37 – – – Yes Yes
   Case 9 Bipolar 23 30 – + + Yes Yes
Deprest et al [51]
   Case 3 Bipolar 19 39 – – – Yes Yes
   Case 4 Bipolar 20 36 – – – Yes Yes
   Case 5 Bipolar 19 36 – – – Yes Yes
   Case 9 Bipolar 23 37 – – – Yes Yes
   Case 10 Bipolar 18 19 + + + No No
Nicolini et al [52]
   Case 10 Bipolar 27 27 + + + No No
   Case 11 Bipolar 24 37 – – – Yes Yes
Bipolar = bipolar diathermy; GW = gestational weeks; IUFD = intrauterine fetal death; Monopolar = monopolar thermocoagulation; PROM = premature
rupture of membranes.
C.P. Chen
Taiwanese J Obstet Gynecol • June 2005 • Vol 44 • No 2112
Table 6. Clinical outcome of acardiac twinning treated with fetoscope-guided funicular occlusion by ligation,
laser coagulation or thermocoagulation
IUFD
Preterm Preterm
Survival
GW at GW at of
delivery or delivery or
of Technical
Authors [Reference] Method
treatment delivery pump
PROM ) 2 PROM
pump success
twin
weeks of ) 32
twin
procedure GW
Deprest et al [51]
   Case 3 Laser + bipolar 19 39 – + + Yes No (laser)
Yes (bipolar)
Quintero et al [53]
   Case 3 Ligation + laser 23 23 + + + No No
   Case 4 Ligation 19 36 – + + Yes Yes
   Case 5 Ligation 23 30 – – + Yes Yes
   Case 6 Ligation 18 37 – – – Yes Yes
   Case 8 Ligation 25 25 – + + No Yes
   Case 9 Ligation 20 32 – – + Yes Yes
   Case 10 Ligation 25 30 – – + Yes No
   Case 11 Ligation 23 26 + – + No Yes
   Case 12 Ligation 20 24 + – + No Yes
   Case 13 Ligation 20 26 + – + No Yes
McCurdy et al [54] Ligation 20 20 + + + No Yes
Quintero et al [55] Ligation 19 36 – – – Yes Yes
Willcourt et al [56] Ligation 24 29 – – + Yes Yes
Deprest et al [57,58]
   Case 2 Ligation + laser 24 30 – – + Yes Yes (ligation)
No (laser)
   Case 3 Ligation + laser 21 25 – + + Yes Yes (ligation)
No (laser)
   Case 4 Ligation 21 29 – + + No Yes
Galinkin et al [59]
   Case 2 Monopolar 22 36 – – – Yes Yes
   Case 3 Ligation hysterotomy 24 38 – – – Yes No (endoscopic
  ligation)
Yes (hysterotomy
  ligation)
Ville et al [60]
   Case 1 Laser 17 39 – – – Yes Yes
   Case 2 Laser 20 38 – – – Yes Yes
   Case 3 Laser 26 29 – – + Yes No
   Case 4 Laser 28 29 – + + Yes No
Hecher et al [61] Laser 16 41 – – – Yes Yes
Arias et al [62] Laser 24 35 – – – Yes Yes
Quintero et al [63] Laser 18 37 – – + Yes Yes
Bipolar = bipolar diathermy; GW = gestational weeks; IUFD = intrauterine fetal death; Monopolar = monopolar thermocoagulation; PROM = premature
rupture of membranes.
cases of delivery or PROM at 32 gestational weeks or
less. However, the applicability of operative fetoscopy is
limited as it requires special instrumentation and
training. Additionally, PROM and premature uterine
contractions are very common following operative
fetoscopy.
Ville et al described the successful application of
endoscope-guided Nd:YAG laser to coagulate the
umbilical cord vessels supplying the acardiac twin in
TRAP [60]. To date, at least 10 cases of fetoscope-
guided funicular laser coagulation have been reported
[51,57,60–63] (Table 6). Among them, five cases were
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technically successful, all pump twins survived, and
there were six cases of delivery or PROM at 32 gestational
weeks or less. The main limitation of this technique is
that the size and water content of Wharton’s jelly after
20 weeks of gestation prevent laser coagulation [61].
Conservative Management Versus Invasive
Treatment
The TRAP sequence is associated with perinatal
mortality ranging from 35% to 55% [11,13]. However,
Sullivan et al, according to their experience with only
one pump twin death in 10 cases of TRAP sequence,
suggested that neonatal mortality of the pump twin in
prenatally diagnosed acardiac twin pregnancies may
be considerably less than reported, and expectant
management with close prenatal surveillance deserves
consideration [64]. Sepulveda and Sebire suggested
that invasive treatment should be considered only in
pregnancies that would potentially benefit from the
prenatal intervention, such as in monochorionic-
monoamniotic pregnancies in which entanglement of
the cords may cause death of the pump twin, when there
is development of polyhydramnios, sonographic
appearance of cardiac insufficiency of the pump twin,
and rapid growth of the acardiac twin [18]. Otherwise,
when there are no poor prognostic factors, conservative
management should be considered. In many cases,
spontaneous cessation of blood supply to the acardiac
twin occurs, and the acardiac twin remains significantly
smaller than the pump twin. Once invasive treatment is
indicated, the simplicity, safety and efficacy of the
chosen technique should be considered. It has been
shown that the intrafetal approach is superior to the
funicular occlusion approach [38]. Ultrasound-guided
intrafetal laser ablation or RFA is believed to be the
treatment of choice based on currently available data
[18].
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